CurrentAnesthesia
Get Weekly

Surgical and respiratory journalCurrentAnesthesia coverage

The Lancet Respiratory Medicine

What CurrentAnesthesia has captured from this journal. The coverage figures describe CurrentAnesthesia's coverage, not the journal's output. Figures as of 28 October 2026.

CurrentAnesthesia holds 57 Briefs from The Lancet Respiratory Medicine, published since 2022, most often randomised controlled trials and cohort studies.

Recent
1 Brief
past 90 days
Archive
57 Briefs
research published Jan 2025 – Sep 2026 and Jan 2023 – Jun 2024
Editorial
–
no Weekly issue published yet

Topics

Evidence types

Shares are of the 57 Briefs CurrentAnesthesia has covered from Lancet Respir Med, by primary topic and study type; a Brief without a primary topic is in no topic row.

Publication activity

Latest from The Lancet Respiratory Medicine

All coverage, newest first

  1. Lancet Respir Med

    NEWS2 versus shock status to stratify antibiotic urgency in patients with suspected sepsis: a retrospective, multicentre cohort study

    Cohort studySepsis & infection

  2. Lancet Respir Med

    Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications (SNaPP): an international, randomised, controlled, phase 4 trial

    Randomised controlled trialPerioperative

  3. Lancet Respir Med

    Effects of inflammatory phenotypes in acute respiratory distress syndrome on mortality and partitioning of lung and chest wall mechanics in patients in the USA and Canada: a retrospective cohort study

    Cohort studyRespiratory failure

  4. Lancet Respir Med

    Biological subphenotypes in severe acute hypoxaemic respiratory failure and acute respiratory distress syndrome using rapid prospective classification (SPARC) in the USA: a multicentre, observational, study

    Cohort studyRespiratory failure

  5. Lancet Respir Med

    Epidemiology, ventilation management, and clinical outcomes in children (PRoVENT-PED): first results from the 10-year, investigator-initiated, international, multicentre, prospective cohort study

    Cohort studyPaediatric

  6. Lancet Respir Med

    Non-invasive respiratory supports and criteria for intubation in randomised trials of acute hypoxaemic respiratory failure: a systematic review and network meta-analysis

    Meta-analysisRespiratory failure

  7. Lancet Respir Med

    Bedside identification of subphenotypes in acute respiratory failure (PHIND): a multicentre, observational cohort study

    Cohort studyRespiratory failure

  8. Lancet Respir Med

    Polymyxin B haemoadsorption in endotoxic septic shock (Tigris): a multicentre, open-label, Bayesian, randomised, controlled, phase 3 trial

    Randomised controlled trialSepsis & infection

  9. Lancet Respir Med

    Procalcitonin testing combined with NEWS2 evaluation compared with usual care based on NEWS2 for identification of sepsis and antibiotic initiation in the emergency department in England and Wales (PRONTO): a multicentre, randomised, controlled, open-label, phase 3 trial

    Randomised controlled trialSepsis & infection

  10. Lancet Respir Med

    Endotracheal surfactant for infants with life-threatening bronchiolitis (BESS): a randomised, blinded, sham-controlled, phase 2 trial

    Randomised controlled trialPaediatric

  11. Lancet Respir Med

    Epidemiology, ventilation, and outcomes of acute respiratory failure in immunocompromised patients from 103 intensive care units in 26 countries: a retrospective observational study

    Cohort studyRespiratory failure

  12. Lancet Respir Med

    Survival effect of prehospital emergency anaesthesia with intubation in risk-stratified patients with major trauma: a causal modelling study

    Research articleTrauma & bleeding

  13. Lancet Respir Med

    Prognostic factors associated with mortality in septic shock: a systematic review and meta-analysis

    Meta-analysisSepsis & infection

  14. Lancet Respir Med

    Blood biomarkers for the prediction of outcome after cardiac arrest: an international prospective observational study within the Targeted Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest (TTM2) trial

    Randomised controlled trialCardiac arrest

  15. Lancet Respir Med

    Hospital and long-term outcomes for subglottic suction and polyurethane cuff versus standard endotracheal tubes in emergency intubation (PreVent 2): a randomised controlled phase 2 trial

    Randomised controlled trialAirway

  16. Lancet Respir Med

    Effects of intraoperative higher versus lower positive end-expiratory pressure during one-lung ventilation for thoracic surgery on postoperative pulmonary complications (PROTHOR): a multicentre, international, randomised, controlled, phase 3 trial

    Randomised controlled trial

  17. Lancet Respir Med

    Association of medication-induced deep sedation and emotional distress during mechanical ventilation with loss of independent living: an observational cohort study

    Cohort studyICU sedation & recovery

  18. Lancet Respir Med

    Association of respiratory drive and effort with mortality and time to discharge in patients on mechanical ventilation in Canada: a longitudinal, prospective, registry-based cohort study

    Cohort studyRespiratory failure

  19. Lancet Respir Med

    Expedited transfer from the scene for refractory out-of-hospital cardiac arrest in Australia: a prospective, multicentre, parallel, open label, randomised clinical trial

    Randomised controlled trialCardiac arrest

  20. Lancet Respir Med

    Evaluating the generalisability of formulas used to set tidal volumes in mechanically ventilated patients: an observational, multicohort, retrospective study

    Cohort studyRespiratory failure

  21. Lancet Respir Med

    Inhaled isoflurane for sedation of mechanically ventilated children in intensive care (IsoCOMFORT): a multicentre, randomised, active-control, assessor-masked, non-inferiority phase 3 trial

    Randomised controlled trialPaediatric

  22. Lancet Respir Med

    Adjunctive corticosteroids in non-AIDS patients with severe Pneumocystis jirovecii pneumonia (PIC): a multicentre, double-blind, randomised controlled trial

    Randomised controlled trialRespiratory failure

  23. Lancet Respir Med

    Optimising trial design for cardiogenic shock: insights from the sixth Critical Care Clinical Trialists Workshop

    Guideline or statementHaemodynamics & fluids

  24. Lancet Respir Med

    Defining and subphenotyping ARDS: insights from an international Delphi expert panel

    Guideline or statementRespiratory failure

  25. Lancet Respir Med

    Effectiveness of nasal high-flow oxygen during apnoea on hypoxaemia and intubation success in paediatric emergency and ICU settings: a randomised, controlled, open-label trial

    Randomised controlled trialPaediatric

  26. Lancet Respir Med

    Preoxygenation strategies for intubation of patients who are critically ill: a systematic review and network meta-analysis of randomised trials

    Meta-analysisAirway

  27. Lancet Respir Med

    Decisions to withdraw or withhold life-sustaining therapies in patients with and without acute brain injury: a secondary analysis of two prospective cohort studies

    Secondary analysisNeuro

  28. Lancet Respir Med

    Perioperative lung expansion and pulmonary outcomes after open abdominal surgery versus usual care in the USA (PRIME-AIR): a multicentre, randomised, controlled, phase 3 trial

    Randomised controlled trialPerioperative

  29. Lancet Respir Med

    In-hospital outcomes and 6-month follow-up results of patients supported with extracorporeal membrane oxygenation for COVID-19 from the second wave to the end of the pandemic (EuroECMO-COVID): a prospective, international, multicentre, observational study

    Cohort studyOrgan support & nutrition

  30. Lancet Respir Med

    Hypothermia for expanded criteria organ donors in kidney transplantation in France (HYPOREME): a multicentre, randomised controlled trial

    Randomised controlled trialOrgan support & nutrition

  31. Lancet Respir Med

    Long-term outcomes of early exposure to repeated general anaesthesia in children with cystic fibrosis (CF-GAIN): a multicentre, open-label, randomised controlled phase 4 trial

    Randomised controlled trialPaediatric

  32. Lancet Respir Med

    High-flow nasal oxygen for children's airway surgery to reduce hypoxaemic events: a randomised controlled trial

    Randomised controlled trialPaediatric

  33. Lancet Respir Med

    Long-term outcomes after treatment of delirium during critical illness with antipsychotics (MIND-USA): a randomised, placebo-controlled, phase 3 trial

    Secondary analysisICU sedation & recovery

  34. Lancet Respir Med

    Association of active mobilisation variables with adverse events and mortality in patients requiring mechanical ventilation in the intensive care unit: a systematic review and meta-analysis

    Meta-analysisICU sedation & recovery

  35. Lancet Respir Med

    Hydrocortisone plus fludrocortisone for community acquired pneumonia-related septic shock: a subgroup analysis of the APROCCHSS phase 3 randomised trial

    Secondary analysisSepsis & infection

  36. Lancet Respir Med

    Individualised, short-course antibiotic treatment versus usual long-course treatment for ventilator-associated pneumonia (REGARD-VAP): a multicentre, individually randomised, open-label, non-inferiority trial

    Randomised controlled trialSepsis & infection

  37. Lancet Respir Med

    Ceftriaxone to prevent early ventilator-associated pneumonia in patients with acute brain injury: a multicentre, randomised, double-blind, placebo-controlled, assessor-masked superiority trial

    Randomised controlled trialNeuro

  38. Lancet Respir Med

    Risk factors for COVID-19-associated pulmonary aspergillosis: a systematic review and meta-analysis

    Meta-analysisOrgan support & nutrition

  39. Lancet Respir Med

    Individualised, perioperative open-lung ventilation strategy during one-lung ventilation (iPROVE-OLV): a multicentre, randomised, controlled clinical trial

    Randomised controlled trialCardiothoracic & vascular

  40. Lancet Respir Med

    Balanced crystalloids versus saline for critically ill patients (BEST-Living): a systematic review and individual patient data meta-analysis

    Meta-analysisOrgan support & nutrition

All 57 Briefs in ExploreShowing the 40 most recently published